Browsing by Author "Norlinah Mohamed Ibrahim"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- PublicationAmelioration of Dystonic Opisthotonus in Pantothenate Kinase‐Associated Neurodegeneration Syndrome with Absent “Eye‐of‐the‐Tiger” Sign Following Bilateral Pallidal Deep Brain Stimulation(2019)
;Nor Amelia Mohd Fauzi ;Norlinah Mohamed Ibrahim ;Shahizon Azura Mohamed Mukari ;Thanabalan JeganZariah Abdul AzizPantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive disorder causing progressive generalized dystonia characterized by neurodegeneration and brain iron accumulation (NBIA) due to pantothenate kinase 2 (PANK2) gene mutations.1 The radiological hallmark of PKAN, the “eye-of-the-tiger” sign, characterized by bilateral hypointensity with central hyperintensity in the globus pallidus on T2-weighted brain Magnetic Resonance Imaging (MRI) may be absent in some cases.2 Hence, clinicians may rely on phenotypic clues to aid diagnosis. Despite genetic advances, treatment for NBIA remains symptomatic. Bilateral globus pallidus internus deep brain stimulation (GPi-DBS) has been successful in PKAN patients refractory generalized dystonia.3 Herein we report a case of an atypical PKAN patient with severe dystonic opisthotonus and absent eye-of-the-tiger sign who obtained significant improvement following bilateral GPi-DBS. - PublicationFrequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia(Springer Nature, 2020-08-03)
;Norlinah Mohamed Ibrahim ;Yue Hui Lau ;Noorasyikin Ariffin ;Siti Hajar Md Desa ;Elena Azizan ;Long Kha Chin ;Shahrul Azmin Md Rani ;Yusnita Yakob ;Santhi Datuk PuvanarajahBart van de WarrenburgSpinocerebellar ataxias (SCA) are highly heterogenous group of neurodegenerative diseases causing progressive cerebellar dysfunction. We report the first description of relative frequencies of the common SCA mutations and of phenotypic characteristics of SCA3 patients among Malaysians. Pooled data from adult Malaysian patients who had undergone genetic testing for SCA 1,2,3,6 and 7 at UKM Medical Centre and Institute for Medical Research from 2017 to 2020 were analysed. Fifteen patients with SCA 3 had detailed clinical phenotype evaluation using Inventory for Non -Ataxia Signs (INAS) and Ataxia Severity evaluation using the Scale for Assessment and Rating of Ataxia (SARA). Out of 152 adults patients who were tested for common SCA mutations, 64(42.1%) patients were tested positive for either SCA 1,2,3,6 or 7. Of the 64 positive cases, 44 (68.9%) patients were diagnosed with SCA 3 followed by SCA 2 in 13(20.3%) patients and SCA 1 in 5 (7.8%) patients. Our findings suggest that Malay race had the highest frequency of SCA (n = 34, 50%), followed by the Chinese (n = 16, 23.5%) and approximately 60 (93.8%) SCA patients had first degree family history. In conclusion, SCA 3 is the commonest SCA in Malaysia, followed by SCA 2 and SCA 1. It is important to develop a proper registry of SCA patients to further understand the true prevalence and local impact of the disease in Malaysia.